Literature DB >> 7600085

Interictal cerebral metabolism and epilepsy in cavernous angiomas.

P Ryvlin1, F Mauguière, M Sindou, J C Froment, L Cinotti.   

Abstract

We studied glucose metabolism in brain tissue surrounding cavernous angioma in 22 patients, using PET, and evaluated its relation to the size, site and epileptogenic nature of the vascular malformation, as well as to the post-surgical seizure outcome. Preoperatively, 18 patients suffered recurrent seizures, the origin of which could be clearly related to the vascular malformation in 14. Brain metabolism surrounding cavernous angiomas was normal in 18 patients (82%), and significantly decreased in four (18%). In these four patients, but in none of the 18 other cases, the vascular malformation disrupted connections between paralimbic areas and the adjacent temporal neocortex where hypometabolism was most pronounced. The latter did not correlate with the size nor with the epileptogenic nature of the cavernomas. Sixteen epileptic patients underwent surgical removal of their cavernoma, without resection of the surrounding cortex. At 1-year postoperatively, seizures have relapsed in seven patients (44%), including those four whose epilepsy could not be clearly related to the vascular malformation. Conversely, the four patients with perilesional hypometabolism on preoperative PET were seizure free postoperatively. Hypometabolism in brain tissue surrounding cavernomas is a rare finding which seems more likely to reflect deafferentation than the epileptogenic process itself.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600085     DOI: 10.1093/brain/118.3.677

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  8 in total

Review 1.  Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series.

Authors:  N F Moran; D R Fish; N Kitchen; S Shorvon; B E Kendall; J M Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

Review 2.  Emerging Use of Ultra-High-Field 7T MRI in the Study of Intracranial Vascularity: State of the Field and Future Directions.

Authors:  J W Rutland; B N Delman; C M Gill; C Zhu; R K Shrivastava; P Balchandani
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

3.  Brain metabolic abnormalities associated with developmental venous anomalies.

Authors:  M Larvie; D Timerman; J A Thum
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-04       Impact factor: 3.825

Review 4.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update.

Authors:  Dario J Englot; Edward F Chang
Journal:  Neurosurg Rev       Date:  2014-02-05       Impact factor: 3.042

5.  Magnetic Resonance Thermometry-Guided Stereotactic Laser Ablation of Cavernous Malformations in Drug-Resistant Epilepsy: Imaging and Clinical Results.

Authors:  D Jay McCracken; Jon T Willie; Brad A Fernald; Amit M Saindane; Daniel L Drane; Daniel L Barrow; Robert E Gross
Journal:  Oper Neurosurg (Hagerstown)       Date:  2015-09-25       Impact factor: 2.703

6.  Focal cortical dysplasia imaging discrepancies between MRI and FDG-PET: Unique association with temporal lobe location.

Authors:  Hajime Yokota; Hiroyuki Uetani; Hiroyuki Tatekawa; Akifumi Hagiwara; Emiko Morimoto; Michael Linetsky; Bryan Yoo; Benjamin M Ellingson; Noriko Salamon
Journal:  Seizure       Date:  2020-08-17       Impact factor: 3.184

7.  7T MRI in epilepsy patients with previously normal clinical MRI exams compared against healthy controls.

Authors:  Rebecca Emily Feldman; Bradley Neil Delman; Puneet Singh Pawha; Hadrien Dyvorne; John Watson Rutland; Jiyeoun Yoo; Madeline Cara Fields; Lara Vanessa Marcuse; Priti Balchandani
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

8.  Intraoperative high-field magnetic resonance imaging, multimodal neuronavigation, and intraoperative electrophysiological monitoring-guided surgery for treating supratentorial cavernomas.

Authors:  Fang-Ye Li; Xiao-Lei Chen; Bai-Nan Xu
Journal:  Chronic Dis Transl Med       Date:  2016-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.